OR WAIT null SECS
May 02, 2012
Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
April 02, 2012
Soaring opioid use creates challenges for new drug development and supply-chain control.
March 02, 2012
Social media use raises questions about applying old standards to new information technology.
February 02, 2012
More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
January 02, 2012
Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
December 02, 2011
Added responsibilities and outside concerns prompt overhaul of agency's structure.
November 02, 2011
Clamor mounts over compromised care and rising costs due to lack of crucial therapies.
October 02, 2011
Manufacturers fund research and reduce prices to tackle diseases.
September 02, 2011
PDUFA renewal legislation sets stage for new policies affecting revenue, resarch, and oversight.
August 02, 2011
Rising imports and overseas production spur realignment of enforcement.